CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

October 17, 2018 Providence News Team

Patients who have relapsed or failed first-line treatment for aggressive forms of B-cell non-Hodgkin lymphoma may qualify to receive a promising CAR T-cell therapy in a new clinical trial at Providence Cancer Institute:

Study: Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-NHL-006) for B-cell non-Hodgkin lymphoma

JCAR017 is an investigational CAR T-cell therapy that modifies a patient’s own T-cells to express proteins called CARs (chimeric antigen receptors), which help T-cells recognize tumor cells and go after them. A Phase I study of JCAR017 in people with aggressive forms of B-cell lymphoma found that it provided “a durable reduction or eradication of cancer,” including complete cancer eradication in just over half of the patients. Read more in Lymphoma News Today.

CAR T-cell therapy is a major research priority for the Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center. Read more about JCAR017 in Immuno-Oncology News, and find out more about adoptive T-cell therapy research at Providence.

Providence is one of only two centers in the United States currently participating in this clinical trial. For more information or to enroll a patient, call our Clinical Research office at 503-215-2614. Call us early for consideration, before the patient receives a salvage therapy or stem cell transplant.

See more studies
New research studies are added frequently. Please visit our website to see all studies in all cancer types currently open at Providence Cancer Institute.

Enter content here

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

Welcome to your journey for creating a healthier you

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

CAR T-cell trial offers promising second-line therapy for B-cell lymphoma

About the Author

Previous Article

Next Article

Most Recent Articles

Find information and latest updates regarding negotiations at Providence Sacred Heart Medical Center.

PLUVICTO operates like a homing missile that specifically targets PSMA-positive prostate cancer cells.

Thanks to innovative improvements, patients at Providence St. Joseph Hospital Eureka’s Level III Trauma Center are now seen within ten minutes of arrival.

New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

Advanced glycation end-products are compounds that form when sugar binds to protein or fat. This happens naturally as we age but can accelerate with certain health conditions and even the way we cook.

Chris Brinegar is a breast cancer survivor, and hopes his story encourages men to lose the stigma to protect their health. Read his story.

Providence Holy Cross Medical Center announced the opening of its newly expanded cardiac rehab gym designed to help patients safely rebuild their strength and confidence after a cardiac event.

Providence Portland Medical Center was designated as a Magnet organization in 2005, 2010, 2015, 2020 by the ANCC Magnet Recognition Program® and they are now applying for redesignation.

Kadlec Clinic Bridge Care

Holy Cross is the first Providence hospital in the San Fernando Valley to offer bronchoscopic lung volume reduction, a minimally invasive treatment for patients with severe COPD and emphysema.

The NICU at Providence Portland Medical Center won third place in an international reading competition.

Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

Doctors at Providence St Jude Medical Center are using advanced methods and state-of-the-art technology to restore vision through laser-assisted cataract surgery.

Improve your heart health with these easy dietary tips focused on balanced nutrition and mindful eating.

A new technology called Pulsed Field Ablation (PFA) is offering patients successful outcomes with fewer complications.

Providence Family Medicine Center has been recognized by the American Heart Association and American Medical Association for its commitment to improving blood pressure control rates.

See an inside look at how Providence Portland Medical Center’s da Vinci machine helps surgeons provide safer, faster care to patients.

Last year, Providence Alaska provided a $30,000 community investment grant to the Alaska Native Heritage Center to help enhance the lives of Alaska Native Elders.